摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3,4-噁噻唑-2-酮,5-(4-氯苯基)- | 17452-79-8

中文名称
1,3,4-噁噻唑-2-酮,5-(4-氯苯基)-
中文别名
——
英文名称
5-(4-chlorophenyl)-1,3,4-oxathiazol-2-one
英文别名
5-(4-chlorophenyl)-2H-1,3,4-oxathiazol-2-one;5-(p-chlorophenyl)-1,3,4-oxathiazol-2-one;5-(p-Chlorphenyl)-1,3,4-oxathiazol-2-on
1,3,4-噁噻唑-2-酮,5-(4-氯苯基)-化学式
CAS
17452-79-8
化学式
C8H4ClNO2S
mdl
——
分子量
213.644
InChiKey
FHAPVFFWHRPZFA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    127.5 °C(Solv: acetone (67-64-1))
  • 沸点:
    299.2±42.0 °C(Predicted)
  • 密度:
    1.56±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    64
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 储存条件:
    存储条件:2-8℃,请保持干燥并密封。

SDS

SDS:fad24e49ab81ed1e8fb6ff71ad6f0a84
查看

反应信息

  • 作为反应物:
    描述:
    1,3,4-噁噻唑-2-酮,5-(4-氯苯基)-盐酸亚硝酸特丁酯 、 lithium hydroxide monohydrate 、 叠氮磷酸二苯酯三乙胺copper(ll) bromide 作用下, 以 四氢呋喃1,4-二氧六环乙酸乙酯乙腈 为溶剂, 反应 62.5h, 生成 4-bromo-3-(4-chlorophenyl)-5-(trifluoromethyl)isothiazole
    参考文献:
    名称:
    [EN] SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS GPR120 AGONISTS
    [FR] COMPOSÉS DE TÉTRAHYDROISOQUINOLINE SUBSTITUÉS UTILES COMME AGONISTES DU GPR120
    摘要:
    本发明涉及一种由公式(I)表示的化合物,以及披露了治疗或预防糖尿病、高脂血症、肥胖、非酒精性脂肪肝炎(NASH)、炎症相关疾病及相关疾病和状况有用的药用可接受盐。这些化合物作为G蛋白偶联受体GPR120的激动剂是有用的。还包含了药物组合物和治疗方法。
    公开号:
    WO2017205193A1
  • 作为产物:
    描述:
    4-氯苯甲酰氯ammonium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 18.0h, 生成 1,3,4-噁噻唑-2-酮,5-(4-氯苯基)-
    参考文献:
    名称:
    3H-1,2,4-Dithiazol-3-one compounds as novel potential affordable antitubercular agents
    摘要:
    Small molecules with oxathiazol-2-one moiety were recently reported as potent inhibitors of Mycobacterium bovis var. bacilli Calmette-Guerin (BCG), among which HT1171 was the most potent and selective proteasome inhibitor. Herein we synthesized a series of novel compounds by bioisosteric replacement of the oxathiazol-2-one ring with 3H-1,2,4-dithiazol-3-one, and also fifteen 1,3,4-oxathiazol-2-one molecules in order for potency comparison and structure-activity relationship elucidation since their antibacterial effects on the virulent strains were not evaluated before. All the compounds were assessed for antitubercular activities on the virulent H37Rv strain by a serial dilution method. Among the tested compounds, 3H-1,2,4-dithiazol-3-one compound 4n was found to be the most active with a lowest MIC90 value of 1 mu g/mL. Furthermore, the cytotoxicities of all the compounds against normal human liver cell line L02 were determined by an MTT method. Compound 4n displayed a lower inhibitory ratio than HT1171 at the concentration of 100 mu M, indicating its better safety profile. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.12.065
  • 作为试剂:
    描述:
    4-氯苯甲酰胺氯羰基亚磺酰氯 、 在 1,3,4-噁噻唑-2-酮,5-(4-氯苯基)- 作用下, 以 甲苯 为溶剂, 反应 16.0h, 以This resulted in 3.8 g (92%) of 5-(4-chlorophenyl)-2H-1,3,4-oxathiazol-2-one as a white solid的产率得到1,3,4-噁噻唑-2-酮,5-(4-氯苯基)-
    参考文献:
    名称:
    US20140275179A1
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • [EN] AROMATIC AMIDES AND USES THEREOF<br/>[FR] AMIDES AROMATIQUES ET LEURS UTILISATIONS
    申请人:BIOTA SCIENT MANAGEMENT
    公开号:WO2012142671A1
    公开(公告)日:2012-10-26
    The present invention provides compounds of Formula (I): and salts, racemates, isomers, diastereoisomers, enantiomers, hydrates, solvates, N-oxides, pharmaceutically acceptable derivatives or prodrugs thereof. Also provided the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.
    本发明提供了化合物的结构式(I):以及它们的盐、消旋体、异构体、对映异构体、立体异构体、水合物、溶剂合物、N-氧化物、药学上可接受的衍生物或前药。还提供了这些化合物作为抗菌剂的用途,包括它们的组合物和制造过程。
  • SUBSTITUTED BENAMIDINES AS ANTIBACTERIAL AGENTS
    申请人:Haydon David John
    公开号:US20100298388A1
    公开(公告)日:2010-11-25
    Compounds of formula (IA) or (IB) have antibacterial activity: wherein W is ═C(H)— or ═N—; R 3 is a radical of formula -(Alk 1 ) m -(Z 1 ) p -(Alk 2 ) n -Q wherein m, p and n are independently 0 or 1, provided that at least one of m, p and n is 1 , Z1 is —O—, —S—, —S(O)—, —S(O 2 )—, —NH—, —N(CH 3 )—, —N(CH 2 CH 3 )—, —C(—O)—, —O—(C═O)—, —C(═O)—O—, or an optionally substituted divalent monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted divalent bicyclic carbocyclic or heterocyclic radical having 5 to 10 ring atoms; Alk 1 and Alk 2 are optionally substituted C 1 -C 6 alkylene, C 2 -C 6 alkenylene, or C 2 -C 6 alkynylene radicals, which may optionally terminate with or be interrupted by —O—, —S—, —S(O)—, —S(O 2 )—, —NH—, —N(CH 3 )—, Or —N(CH 2 CH 3 )—; and Q is hydrogen, halogen, nitrile, or hydroxyl, or an optionally substituted monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted bicyclic carbocyclic or heterocyclic radical having 5 to 10 ring atoms; R 4 and R 5 are optional substituents; and R 2 , R 6 and R 7 are independently hydrogen or a radical of formula -(Alk 3 ) x -(Z 2 )y-(Alk 4 ) z -H wherein x, y and z are independently 0 or 1, Z 2 is —O—, —S—, —S(O)—, —S(O 2 )—, —NH—, —N(CH 3 )—, —N(CH 2 CH 3 )—, —C(—O)—, —O—(C═O)— or —C(═O)—O—; Alk 3 and Alk 4 are optionally substituted C 1 -C 3 alkylene, C 2 -C 3 alkenylene, or C 2 -C 3 alkynylene radicals, which may optionally terminate with or be interrupted by —O—, —S—, —S(O)—, —S(O 2 )—, —NH—, —N(CH 3 )—, or —N(CH 2 CH 3 )—.
    化合物的结构式(IA)或(IB)具有抗菌活性:其中W为 ═C(H)— 或 ═N—;R3为具有以下结构的基团 -(Alk1)m-(Z1)p-(Alk2)n-Q,其中m、p和n独立地为0或1,但至少m、p和n中的一个为1,Z1为—O—、—S—、—S(O)—、—S(O2)—、—NH—、—N(CH3)—、—N(CH2CH3)—、—C(—O)—、—O—(C═O)—、—C(═O)—O—,或者具有3至6个环原子的可选择取代的一元环碳环或杂环基团;或者具有5至10个环原子的可选择取代的二元环碳环或杂环基团;Alk1和Alk2为可选择取代的C1-C6烷基、C2-C6烯基或C2-C6炔基基团,可能以—O—、—S—、—S(O)—、—S(O2)—、—NH—、—N(CH3)—、或—N(CH2CH3)—终止或中断;Q为氢、卤素、腈基或羟基,或者具有3至6个环原子的可选择取代的一元环碳环或杂环基团;或者具有5至10个环原子的可选择取代的二元环碳环或杂环基团;R4和R5为可选取代基团;R2、R6和R7独立地为氢或具有以下结构的基团 -(Alk3)x-(Z2)y-(Alk4)z-H,其中x、y和z独立地为0或1,Z2为—O—、—S—、—S(O)—、—S(O2)—、—NH—、—N(CH3)—、—N(CH2CH3)—、—C(—O)—、—O—(C═O)—或—C(═O)—O—;Alk3和Alk4为可选择取代的C1-C3烷基、C2-C3烯基或C2-C3炔基基团,可能以—O—、—S—、—S(O)—、—S(O2)—、—NH—、—N(CH3)—或—N(CH2CH3)—终止或中断。
  • Dithiazoles and related compounds. Part 3. Preparation of 5H-1,4,2-dithiazoles via 1,3-dipolar cycloadditions between nitrile sulphides and thiocarbonyl compounds, and some conversions into 3,5-diaryl-1,4,2-dithiazolium salts
    作者:Kwok-Fai Wai、Michael P. Sammes
    DOI:10.1039/p19910000183
    日期:——
    Thermolysis of 1,3,4 -oxathiazol-2-ones 3 in the presence of thiocarbonyl compounds gives modest to good yields of the little-known 5H-1,4,2-dithiazoles 1, the reaction being successful with diaryl, aryl alkyl and dialkyl ketones, and thiono esters, but failing with dithio esters and tertiary thioamides. The influence of substituents is discussed. Solvolysis of 5-ethoxy-5H-1,4,2-dithiazoles, derived
    在硫代羰基化合物的存在下,对1,3,4-氧杂噻唑-2-酮3的热解反应可得到中等程度的中等收率的鲜为人知的5 H -1,4,2-二噻唑1,该反应可成功地与二芳基,芳基烷基和二烷基酮,以及硫代酸酯,但不能与二硫代酯和叔硫代酰胺结合使用。讨论了取代基的影响。5-乙氧基-5 H -1,4,2-二噻唑类化合物,由硫代酸酯衍生,与高氯酸在乙酸酐中溶剂化,可高产率生成3,5-二芳基-1,4,2-二噻唑鎓盐9。
  • 3-Aryl-4-isoxazolecarboxylic acids as plant growth regulants
    申请人:Monsanto Company
    公开号:US04144047A1
    公开(公告)日:1979-03-13
    3-Aryl-4-isothiazolecarboxylic acids as well as 3-aryl-4-isoxazolecarboxylic acids have been found to be effective plant growth regulants especially when applied to soybean plants.
    3-芳基-4-异噻唑羧酸以及3-芳基-4-异噁唑羧酸已被发现是有效的植物生长调节剂,尤其是在应用于大豆植物时。
  • 3-Aryl-4-isothiazolecarboxylic acid and 3-aryl-4-isoxazolecarboxylic
    申请人:Monsanto Company
    公开号:US04187099A1
    公开(公告)日:1980-02-05
    Carboxylic acid derivatives having the formula ##STR1## have been found to be effective herbicides. They are especially effective when applied as a pre-emergent herbicide.
    具有式##STR1##的羧酸衍生物已被发现是有效的除草剂。它们作为芽前除草剂使用时尤为有效。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐